Form 4: Neeleman Adjusts HealthEquity Holdings

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reported a series of transactions involving common stock and stock options.

Summary

• Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc. (HQY), has reported transactions related to his beneficial ownership of the company's securities.
• On April 6, 2026, Neeleman acquired 2,559 shares of common stock at a price of $83.8363 per share.
• Following this transaction, Neeleman directly holds 138,668 shares of common stock.
• Additionally, he has indirect beneficial ownership of 409,735 shares held by the Stephen and Christine Neeleman Trust, 140,000 shares held by his spouse, and 203,000 shares held by Neeleman Family Holdings, LLC, of which he is the manager.
• The filing also details several stock options, all of which are immediately exercisable, with varying exercise prices and underlying common stock amounts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions without providing new strategic information or significant changes in holdings that would strongly influence sentiment.

Positives

• Acquisition of 2,559 shares of common stock by a key executive.
• Continued significant beneficial ownership through direct holdings, trusts, and family entities, indicating ongoing commitment.
• All reported stock options are immediately exercisable.

Negatives

• The filing does not provide context for the acquisition, such as whether it was part of a pre-arranged trading plan or a discretionary purchase.
• Details on the disposition of any securities are not provided in this specific filing.

Risks

• The filing does not explicitly mention any risks. However, as with any executive stock transaction, market perception and potential insider selling could be a concern for investors if not accompanied by clear strategic rationale.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing. The document focuses on reporting past transactions.

Management Comments

• Stephen Neeleman disclaims beneficial ownership of securities held by his spouse and Neeleman Family Holdings, LLC, except to the extent of his pecuniary interest, and states these reports should not be deemed admissions of beneficial ownership for Section 16 or other purposes.
• All stock options reported are immediately exercisable.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The reported acquisition of common stock by a founder and Vice Chairman at a price of $83.8363 is a routine event, but the aggregate indirect holdings underscore significant insider stake in HealthEquity.

Related Party Transactions

• Indirect beneficial ownership of 409,735 shares by the Stephen and Christine Neeleman Trust.
• Indirect beneficial ownership of 140,000 shares by Reporting Person's spouse.
• Indirect beneficial ownership of 203,000 shares by Neeleman Family Holdings, LLC, where Stephen Neeleman is the manager.

Stakeholder Impact

• Shareholders: The acquisition of shares by a key executive may be viewed positively, suggesting confidence in the company, but the overall impact is limited without further context.
• Employees: No direct impact mentioned.
• Creditors: No direct impact mentioned.
• Suppliers/Customers: No direct impact mentioned.

Next Steps

• Continued monitoring of future Form 4 filings by Stephen Neeleman and other insiders for further insights into their investment activities.
• Analysis of HealthEquity's overall financial performance and strategic announcements to contextualize insider transactions.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Stephen Neeleman, Executive Transactions, SEC Filing